Cargando…

Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation

Candida species remains one of the most important causes of opportunistic infections worldwide. Invasive candidiasis (IC) is associated with considerable morbidity and mortality in liver disease (LD) patients if not treated promptly. Echinocandins are often recommended as a first-line empirical trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeoh, Siang Fei, Lee, Tae Jin, Chew, Ka Lip, Lin, Stephen, Yeo, Dennis, Setia, Sajita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985852/ https://www.ncbi.nlm.nih.gov/pubmed/29881298 http://dx.doi.org/10.2147/IDR.S165676

Ejemplares similares

Echinocandins - first line in invasive candidiasis: how strong is this 'strong' evidence?
por: Gonçalves-Pereira, João, et al.
Publicado: (2011)

Incidence of Invasive Fungal Infections in Liver Transplant Recipients under Targeted Echinocandin Prophylaxis
por: Breitkopf, Robert, et al.
Publicado: (2023)

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
por: Grau, S, et al.
Publicado: (2015)

Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients
por: Prigent, Gwénolé, et al.
Publicado: (2017)

Invasive Fungal Breakthrough Infections under Targeted Echinocandin Prophylaxis in High-Risk Liver Transplant Recipients
por: Breitkopf, Robert, et al.
Publicado: (2023)

Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia
por: Sakai, Daiki, et al.
Publicado: (2021)

Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis
por: Lotfali, Ensieh, et al.
Publicado: (2022)

Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features
por: Pérez-González, Noelia, et al.
Publicado: (2023)

157. A Multicenter, Mixed-Method Evaluation of Delayed Hospital Discharge in Patients with Invasive Candidiasis Receiving Echinocandins
por: Jo, Jinhee, et al.
Publicado: (2021)

Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive Candidiasis
por: Murri, Rita, et al.
Publicado: (2021)

Presence of Candida spp. and candidiasis in liver transplant patients
por: dos Santos, Samantha Bertoncello, et al.
Publicado: (2018)

Severe Cutaneous Candidiasis in a Liver Transplant Patient
por: Badiee, P., et al.
Publicado: (2019)

In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex
por: Chew, Ka Lip, et al.
Publicado: (2021)

Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication
por: Vekeman, Francis, et al.
Publicado: (2018)

2116. Comparative Effectiveness of Amphotericin B, Azoles, and Echinocandins in the Treatment of Candidemia and Invasive Candidiasis: A Systematic Review and Network Meta-Analysis
por: Demir, Koray K, et al.
Publicado: (2019)

Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak
por: Szekely, Jidapa, et al.
Publicado: (2023)

Candidiasis by Candida glabrata, Candida nivariensis and Candida bracarensis in Galleria mellonella: Virulence and Therapeutic Responses to Echinocandins
por: Hernando-Ortiz, Ainara, et al.
Publicado: (2021)

Invasive Candidiasis due to Candida Norvegensis in a Liver Transplant Patient: Case Report and Literature Review
por: Musso, Maria, et al.
Publicado: (2014)

635. Is Azole Prophylaxis in Liver Transplant Recipients Effective in Preventing Invasive Candidiasis in the Era of Emerging Resistance?
por: Gurram, Pooja R, et al.
Publicado: (2022)

Demographics and health care seeking behavior of Singaporean women with chronic constipation: implications for therapeutic management
por: Gwee, Kok Ann, et al.
Publicado: (2012)

Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis
por: Gatti, Milo, et al.
Publicado: (2021)

Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant Candida tropicalis and Candida glabrata isolates with delineation of their resistance mechanisms
por: Xiao, Meng, et al.
Publicado: (2018)

Significantly Improved Pharmacokinetics Enhances In Vivo Efficacy of APX001 against Echinocandin- and Multidrug-Resistant Candida Isolates in a Mouse Model of Invasive Candidiasis
por: Zhao, Yanan, et al.
Publicado: (2018)

Comparison of echinocandin antifungals
por: Eschenauer, Gregory, et al.
Publicado: (2007)

Fungal echinocandin resistance
por: Walker, Louise A., et al.
Publicado: (2010)

Fungal echinocandin resistance
por: Munro, Carol A
Publicado: (2010)

Digital Transformation in Medical Affairs Sparked by the Pandemic: Insights and Learnings from COVID-19 Era and Beyond
por: Furtner, Daniel, et al.
Publicado: (2021)

Evaluation of the Efficacy of CD101, a Novel Echinocandin, in the Treatment of Candida auris Infection Using a Murine Model of Disseminated Candidiasis
por: Hager, Christopher, et al.
Publicado: (2017)

1726. Candida albicans Virulence Genes Induced During Intra-abdominal Candidiasis (IAC) in the Absence of Antifungal Exposure Mediate Echinocandin Resistance
por: Clancy, Cornelius J, et al.
Publicado: (2019)

Hypertension and blood pressure variability management practices among physicians in Singapore
por: Setia, Sajita, et al.
Publicado: (2017)

Invasive candidiasis serological diagnosis in solid organ transplant recipients
por: Piskorska, Katarzyna, et al.
Publicado: (2014)

In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis
por: Boikov, Dina A., et al.
Publicado: (2017)

Drug–drug interactions involving antidepressants: focus on desvenlafaxine
por: Low, Yvette, et al.
Publicado: (2018)

“Illuminating” Echinocandins’ Mechanism of Action
por: Loh, Boon Shing, et al.
Publicado: (2020)

468. Assessment of The Proportion of Hospitalized Patients (Pts) with Candidemia (C) and Invasive Candidiasis without Candidemia (IC) Who Received an Echinocandin (EC) and Were Potentially Eligible for an Earlier Hospital Discharge (HD)
por: Lodise, Thomas, et al.
Publicado: (2022)

Isavuconazole and Liposomal Amphotericin B as Successful Combination Therapy of Refractory Invasive Candidiasis in a Liver Transplant Recipient: A Case Report and Literature Review
por: Odysseos, Georgios, et al.
Publicado: (2021)

The in vitro Activity of Echinocandins Against Clinical Trichophyton rubrum Isolates and Review of the Susceptibility of T. rubrum to Echinocandins Worldwide
por: Su, Huilin, et al.
Publicado: (2023)

Echinocandin-resistant Candida tropicalis Bloodstream Infections
por: Sfeir, Maroun, et al.
Publicado: (2017)

Management of early graft candidiasis in a kidney transplant recipient
por: Tan, Jaimee, et al.
Publicado: (2022)

Diagnosis of invasive candidiasis in the ICU
por: Eggimann, Philippe, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5d0eokiugumql3j2qs89fur99v